This article was automatically translated from HIBAPRESS, the Arabic version:
Hibapress
The Moroccan Blood Agency and its derivatives launched, on Thursday in Tangier, its national tour, under the theme “towards health sovereignty in the blood field … A territorial transfusion system at the service of Morocco of the regions”. This major national tour, the first step of which starts in the Tangier-Tétouan-Al Hoceima region, is involved in accordance with high royal orientations aimed at deeply restructuring the national health system and establishing new governance in the sector, and is part of the strategic missions which incumbent on the agency to modernize and structure the governance of the transfusion national system.
It is also part of the new national dynamic of reform of the health system, and in the context of the progressive deployment of territorial health groups (GST), with the designation of Tangier-Tétouan-Al Hoceima as a pilot region, with a view to the generalization of this model to all regions of the kingdom.
The agency, in a proactive approach, has thus decided to make this stage the starting point of its tour, in order to strengthen the convergence and complementarity of national health reforms.
Speaking on this occasion, the director of the Moroccan Blood Agency and its derivatives, Kamal Doghmi, stressed that this meeting marks a historic turning point in the transfusion reform of Morocco, and this in line with the high royal orientations, specifying that this tour is not a communication operation, but a strategic, territorial and structuring approach.
Mr. Doghmi said that the choice of this region is aligning with the strategy of the Ministry of Health and Social Protection, which launched a pilot experiment in the GST in this area, stressing that the objective is to build a national blood policy based on a real inventory, active listening in players in the field and governance aligned with regional specificities.
“We want to move from a logic of centralized management to a logic of delegated regulation, regional performance and measurable results,” he said, recalling that blood is a strategic good and the ambition is to achieve full and whole health sovereignty in this area by 2030.
In this regard, he pointed out that the involvement of university hospital centers (CHU), regional departments and hospitals, as a pillars of transfusion excellence, is crucial, noting that the agency also intends to structure its collaboration with the private sector in a responsible spirit of complementarity.
For his part, the dean of the Faculty of Medicine and Pharmacy of Tangier, Abdallah Oulmaati, noted that the faculty is aware of his role in terms of training and continuing education of health personnel (teachers, doctors and nurses), to improve the quality of service in this area, noting that the objective is to lead to health sovereignty, in accordance with high royal orientations.
This meeting was marked by the presentation of a presentation emphasizing the objectives, the mission and the attributions of the agency, as well as by discussions with regional officials, in order to identify the concrete challenges and to co-construct solutions to optimize the governance of the blood sector and its derivatives.
It was also punctuated by the installation of the regional representative of the agency in Tangier-Tétouan-Al Hoceima, Jaidann Khalid.
Mr. Jaidann noted that his appointment represents for him a responsibility to ensure the quality and availability of blood and its derivatives at the level of health establishments in the northern region, noting that among the measures envisaged are the restructuring of the transfusion system at the level of the region, the increase in the number of mobile blood collections, the implementation of the necessary human and material resources and the promotion of the awareness of citizens. This strategic tour, which is fully part of the royal national health system reform, adopts a global territorial approach aimed at establishing a precise and integrated diagnosis of the situation in the blood sector at national and regional levels. The objective is to produce a realistic inventory of the sector, with the direct participation of the main players in the health system at the territorial level.
The agency thus intends to launch, from this region, a participatory dynamic for the development of an inclusive national policy of blood and its derivatives, taking into account the territorial specificities of each region.
Through this approach, the agency aims to involve all stakeholders, including the private sector, by the organization of a national meeting intended to strengthen cooperation between the components of the national health system.
This policy is based on the principle of consolidating health sovereignty in the blood field, consistent with the strategic objectives of the Royal Project of Advanced Regionalization, and in order to guarantee efficiency and performance in the management of transfusion resources on a regional scale.
The tour will include the installation of regional representatives of the agency, thus marking the effective start of its territorial anchoring in all the regions of the kingdom.
Through this initiative, the Moroccan Blood Agency and its derivatives reaffirms its firm commitment to build a national, secure and sustainable transfusion system, at the service of all the citizens of the kingdom, in perfect adequacy with the high orientations of SM Le Roi Mohammed VI, in favor of a strong, integrated and fair health system.
